产品简要
公司名称 :
伯乐(Bio-Rad)公司
其他品牌 :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
产品类型 :
抗体
产品名称 :
兔抗NFkB p65
目录 :
AHP288
规格 :
0.1毫升
价格 :
712美元
克隆性 :
多克隆
宿主 :
domestic rabbit
共轭标签 :
未共轭
反应物种 :
人类
应用 :
免疫印迹, 酶联免疫吸附测定, 免疫细胞化学, 免疫沉淀
更多信息或购买 :
图像
图像 1 :
伯乐(Bio-Rad)公司 AHP288 图像 1
Published customer image: . Rabbit anti NF Bp65 antibody used for the evaluation of NF&kappab expression in muring kidney by immunofluorescence. Image caption: . Response of vascular endothelial cells in human kidney in organ culture to TL1A. Confocal images of kidney organ culture incubated with either culture media alone or with TL1A (0.2 μg/ml) or TNF (5 ng/ml) for 3 hours at 37°C. (A-C) cultures incubated in media alone show EC staining for NF- Bp65 (green) in both the glomerular (inset) and in peritubular vassels. Some peritubular vessels EC showed positive staining for DR3 (red). (D-F) Cultures treated with TL1A show co-staining for NF- Bp65 (green) and DR3 (red) in EC of some blood vessel (arrows). Inset; show no signal for NF- Bp65 on glomerular EC. (G-I) In contrast, TNF-treated cultures show a strong signal for NF- B p65 (green) in EC of glomerular (inset) and peritubular blood vessels. DR3 (red) is present only in EC of peritubular blood vessels negative for NF- B p65. (Original Mags; x40). From: Wang J, Al-Lamki RS, Zhu X, Liu H, Pober JS, Bradley JR. TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells. BMC Nephrol. 2014 Nov 16;15:178 .
产品信息
Entity Type :
多克隆抗体
Entity Category :
抗体
ProductCode :
AHP288
描述 :
兔抗NFkB p65
特异性 :
NFkB p65
目标物种 :
人类
宿主 :
格式 :
血清
Isotypes :
多克隆IgG
应用 :
免疫沉淀, IF, GS, E, 免疫印迹
ApplicationTypes :
Western Blotting,ELISA,Immunofluorescence,Immunoprecipitation,Gel Super Shift Assays
交叉活性 :
小鼠, 大鼠
规格 :
0.1毫升
Quantity Value :
0.1
规格类型 :
毫升
GO登录号 :
GO:0005829, GO:0005667, GO:0006916, GO:0006954, GO:0008063, GO:0006968, GO:0002756, GO:0003705, GO:0003682, GO:0002755, GO:0070555, GO:0070491, GO:0051092, GO:0051607, GO:0070431, GO:0010224, GO:0042802, GO:0010843, GO:0019221, GO:0016563, GO:0016564, GO:0031625, GO:0031293, GO:0019901, GO:0034130, GO:0032582, GO:0033613, GO:0034138, GO:0034134, GO:0042301, GO:0034142, GO:0043123, GO:0044419, GO:0045087, GO:0045944, GO:0048011, GO:0047485, GO:0050727, GO:0050852, GO:0051059
GOTerms :
MyD88-dependent TLR signaling pathway,MyD88-dependent toll-like receptor signalling pathway,MyD88-independent TLR signaling pathway,MyD88-independent toll-like receptor signalling pathway,lamin/chromatin binding,microtubule/chromatin interaction,nuclear membrane vesicle binding to chromatin,apoptosis inhibitor activity,cellular defence response,GO:0016066,GO:0016067,Tl signaling pathway,Tl signalling pathway,Toll signalling pathway,isoform-specific homophilic binding,protein homopolymerization,response to medium wave ultraviolet light stimulus,response to medium wave ultraviolet radiation stimulus,response to UVB light stimulus,response to UV-B light stimulus,response to UVB radiation stimulus,response to UV-B radiation stimulus,DNA binding, transcription promoter,GO:0003710,transcription activating factor,transcriptional activator activity,negative transcriptional regulator activity,transcriptional repressor activity,cytokine and chemokine mediated signaling pathway,cytokine mediated signalling pathway,membrane protein solubilization,ubiquitin ligase binding,down regulation of gene-specific transcription,down-regulation of gene-specific transcription,downregulation of gene-specific transcription,inhibition of gene-specific transcription,GO:0001107,transcription activator binding,TLR1 signaling pathway,toll-like receptor 1 signalling pathway,TLR2 signaling pathway,toll-like receptor 2 signalling pathway,TLR3 signaling pathway,toll-like receptor 3 signalling pathway,TLR4 signaling pathway,toll-like receptor 4 signalling pathway,activation of I-kappaB kinase/NF-kappaB cascade,stimulation of I-kappaB kinase/NF-kappaB cascade,up regulation of I-kappaB kinase/NF-kappaB cascade,up-regulation of I-kappaB kinase/NF-kappaB cascade,upregulation of I-kappaB kinase/NF-kappaB cascade,interaction with another species,interspecies interaction,interspecies interaction with other organisms,GO:0002226,nonspecific immune response,activation of transcription from RNA polymerase II promoter,positive regulation of transcription from Pol II promoter,stimulation of transcription from RNA polymerase II promoter,up regulation of transcription from RNA polymerase II promoter,upregulation of transcription from RNA polymerase II promoter,up-regulation of transcription from RNA polymerase II promoter,amino-terminal binding,amino-terminus binding,NH2-terminal binding,NH2-terminus binding,N-terminal binding,N-terminal end binding,nerve growth factor receptor signalling pathway,NGF receptor signaling pathway,NGF receptor signalling pathway,T lymphocyte receptor signaling pathway,T lymphocyte receptor signalling pathway,T-cell receptor signaling pathway,T-cell receptor signalling pathway,TCR signaling pathway,T-lymphocyte receptor signaling pathway,T-lymphocyte receptor signalling pathway,activation of NF-kappaB,activation of NF-kappaB transcription factor,NF-kappaB activation,antiviral response,defence response to virus,defense response to viruses,NOD2 signaling pathway,nucleotide-binding oligomerization domain containing 2 signalling pathway,response to IL-1
UniProt数据库登录号 :
Q04206
基因 :
RELA
GeneID网址 :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5970
Entity Formats :
血清
UNSPSC :
41116161
产品形式 :
血清-液体
PriceGBP :
445
PriceEUR :
525
PriceUSD :
712美元
PriceCHF :
571
PriceSEK :
5723
PriceNOK :
5751
PriceDKK :
3914
NotForSaleInCountries :
澳大利亚
更多信息或购买 :
公司信息
伯乐(Bio-Rad)公司
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
44-1865-852-700
公司总部: 英国
伯乐(Bio-Rad)公司是世界领先的抗体生产商之一。通过其原名为AbD Serotec公司的专业抗体业务团队,提供超过12,000种抗体及相关试剂,专注于免疫学、肿瘤、兽医研究及细胞生物学等领域。
抗体产品包括细胞凋亡试剂盒,自噬检测试剂,CD分子标记物,标签抗体,免疫学研究抗体,神经科学研究抗体和兽医应用试剂等。
伯乐(Bio-Rad)公司在英国拥有经ISO9001和ISO13485认证的生产厂房,同时在德国和美国均设有经ISO9001认证的厂房。
我们专业领域已扩展到传统和重组抗体制备及生产服务。我们的抗体定制服务仅需8周就能完成抗体制备并且成功率在90%以上。我们的体外重组抗体技术能够使得我们筛选制备针对具有挑战性的靶点的抗体,确保长期稳定供货,并能够提供抗体的相应基因序列。
伯乐(Bio-Rad)公司 致力于提供帮助您成功的抗体。我们专注于提供技术、产品及相关所有支持信息以协助您出色完成相关科学研究。